Suppr超能文献

B类G蛋白偶联受体激活的分子机制:来自肾上腺髓质素受体的见解

Molecular Mechanisms of Class B GPCR Activation: Insights from Adrenomedullin Receptors.

作者信息

Garelja Michael L, Au Maggie, Brimble Margaret A, Gingell Joseph J, Hendrikse Erica R, Lovell Annie, Prodan Nicole, Sexton Patrick M, Siow Andrew, Walker Christopher S, Watkins Harriet A, Williams Geoffrey M, Wootten Denise, Yang Sung H, Harris Paul W R, Hay Debbie L

机构信息

School of Biological Sciences, University of Auckland, Auckland, 1010, New Zealand.

Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland, Auckland, 1010, New Zealand.

出版信息

ACS Pharmacol Transl Sci. 2020 Feb 26;3(2):246-262. doi: 10.1021/acsptsci.9b00083. eCollection 2020 Apr 10.

Abstract

Adrenomedullin (AM) is a 52 amino acid peptide that plays a regulatory role in the vasculature. Receptors for AM comprise the class B G protein-coupled receptor, the calcitonin-like receptor (CLR), in complex with one of three receptor activity-modifying proteins (RAMPs). The C-terminus of AM is involved in binding to the extracellular domain of the receptor, while the N-terminus is proposed to interact with the juxtamembranous portion of the receptor to activate signaling. There is currently limited information on the molecular determinants involved in AM signaling, thus we set out to define the importance of the AM N-terminus through five signaling pathways (cAMP production, ERK phosphorylation, CREB phosphorylation, Akt phosphorylation, and IP production). We characterized the three CLR:RAMP complexes through the five pathways, finding that each had a distinct repertoire of intracellular signaling pathways that it is able to regulate. We then performed an alanine scan of AM from residues 15-31 and found that most residues could be substituted with only small effects on signaling, and that most substitutions affected signaling through all receptors and pathways in a similar manner. We identify F18, T20, L26, and I30 as being critical for AM function, while also identifying an analogue (AM G19A) which has unique signaling properties relative to the unmodified AM. We interpret our findings in the context of new structural information, highlighting the complementary nature of structural biology and functional assays.

摘要

肾上腺髓质素(AM)是一种由52个氨基酸组成的肽,在脉管系统中发挥调节作用。AM的受体包括B类G蛋白偶联受体、降钙素样受体(CLR),它与三种受体活性修饰蛋白(RAMP)之一形成复合物。AM的C末端参与与受体细胞外结构域的结合,而N末端则被认为与受体的近膜部分相互作用以激活信号传导。目前关于AM信号传导所涉及的分子决定因素的信息有限,因此我们着手通过五条信号通路(cAMP产生、ERK磷酸化、CREB磷酸化、Akt磷酸化和IP产生)来确定AM N末端的重要性。我们通过这五条通路对三种CLR:RAMP复合物进行了表征,发现每种复合物都有一套独特的能够调节的细胞内信号通路。然后我们对AM的15 - 31位残基进行了丙氨酸扫描,发现大多数残基被取代时对信号传导的影响很小,并且大多数取代以类似的方式影响所有受体和通路的信号传导。我们确定F18、T20、L26和I30对AM功能至关重要,同时还鉴定出一种类似物(AM G19A),其相对于未修饰的AM具有独特的信号特性。我们结合新的结构信息来解释我们的发现,突出了结构生物学和功能测定的互补性质。

相似文献

1
Molecular Mechanisms of Class B GPCR Activation: Insights from Adrenomedullin Receptors.
ACS Pharmacol Transl Sci. 2020 Feb 26;3(2):246-262. doi: 10.1021/acsptsci.9b00083. eCollection 2020 Apr 10.
5
Receptor Activity-modifying Proteins 2 and 3 Generate Adrenomedullin Receptor Subtypes with Distinct Molecular Properties.
J Biol Chem. 2016 May 27;291(22):11657-75. doi: 10.1074/jbc.M115.688218. Epub 2016 Mar 24.
7

引用本文的文献

3
Variable CGRP family peptide signaling durations and the structural determinants thereof.
Biochem Pharmacol. 2024 Jun;224:116235. doi: 10.1016/j.bcp.2024.116235. Epub 2024 Apr 24.
4
Cryo-EM Structure of the Human Amylin 1 Receptor in Complex with CGRP and Gs Protein.
Biochemistry. 2024 May 7;63(9):1089-1096. doi: 10.1021/acs.biochem.4c00114. Epub 2024 Apr 11.
5
Clinical Potential of Adrenomedullin Signaling in the Cardiovascular System.
Circ Res. 2023 Apr 28;132(9):1185-1202. doi: 10.1161/CIRCRESAHA.123.321673. Epub 2023 Apr 27.
6
Shared and independent roles of CGRP and PACAP in migraine pathophysiology.
J Headache Pain. 2023 Apr 3;24(1):34. doi: 10.1186/s10194-023-01569-2.
7
Elucidating the Interactome of G Protein-Coupled Receptors and Receptor Activity-Modifying Proteins.
Pharmacol Rev. 2023 Jan;75(1):1-34. doi: 10.1124/pharmrev.120.000180. Epub 2022 Dec 8.
9
CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond.
Physiol Rev. 2023 Apr 1;103(2):1565-1644. doi: 10.1152/physrev.00059.2021. Epub 2022 Dec 1.
10
Determining the Effects of Differential Expression of GRKs and β-arrestins on CLR-RAMP Agonist Bias.
Front Physiol. 2022 Mar 29;13:840763. doi: 10.3389/fphys.2022.840763. eCollection 2022.

本文引用的文献

1
Structure and Dynamics of Adrenomedullin Receptors AM and AM Reveal Key Mechanisms in the Control of Receptor Phenotype by Receptor Activity-Modifying Proteins.
ACS Pharmacol Transl Sci. 2020 Mar 20;3(2):263-284. doi: 10.1021/acsptsci.9b00080. eCollection 2020 Apr 10.
3
The Molecular Control of Calcitonin Receptor Signaling.
ACS Pharmacol Transl Sci. 2019 Jan 11;2(1):31-51. doi: 10.1021/acsptsci.8b00056. eCollection 2019 Feb 8.
4
Molecular Signature for Receptor Engagement in the Metabolic Peptide Hormone Amylin.
ACS Pharmacol Transl Sci. 2018 Apr 23;1(1):32-49. doi: 10.1021/acsptsci.8b00002. eCollection 2018 Sep 14.
6
Shear stress-induced endothelial adrenomedullin signaling regulates vascular tone and blood pressure.
J Clin Invest. 2019 Jun 17;129(7):2775-2791. doi: 10.1172/JCI123825.
7
Substituted Pyridazin-3(2 H)-ones as Highly Potent and Biased Formyl Peptide Receptor Agonists.
J Med Chem. 2019 May 23;62(10):5242-5248. doi: 10.1021/acs.jmedchem.8b01912. Epub 2019 May 13.
8
Circulating Biologically Active Adrenomedullin Predicts Organ Failure and Mortality in Sepsis.
Ann Lab Med. 2019 Sep;39(5):454-463. doi: 10.3343/alm.2019.39.5.454.
9
Structure and dynamics of the active human parathyroid hormone receptor-1.
Science. 2019 Apr 12;364(6436):148-153. doi: 10.1126/science.aav7942.
10
Biased Receptor Signaling in Drug Discovery.
Pharmacol Rev. 2019 Apr;71(2):267-315. doi: 10.1124/pr.118.016790.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验